Man lifting weights at the gym while using a CGM system on his arm.

What Is Continuous Glucose Monitoring (CGM)?

Find out more about CGMs and if Eversense CGM is right for you.

Get Started

Continuous Glucose Monitoring (CGM)

Continuous Glucose Monitoring (CGM) automatically tracks glucose values every 5 minutes with an inserted sensor placed into the skin. This allows you to see your glucose levels anytime at a glance. Using the data from the continuous readings a CGM system can predict glucose directions and provide trends and insights that can help you stay on top of your diabetes management.

The Only Implantable Sensor For Long-Terms Wear

While all CGM systems use transcutaneous sensors that are inserted into the skin and last 7-14 days, the Eversense sensor is inserted completely under the skin. The Eversense CGM system lasts up to 6 months — eliminating the hassle and discomfort of frequent sensor insertions. Simply put, it makes managing your diabetes so much easier.

 

LEARN MORE
Two women with Eversense CGM devices walking outdoors.

"What I Love About Eversense Is Knowing What S Going On All The Time.*"

- Dianne, Eversense CGM User -

HEAR MORE FROM PATIENTS

More Resources You May Like

Woman using her laptop to research the wireless glucose monitor CGM app.

Download and review comprehensive user guides.

View user guides >
Salesman smiling with headphones answers questions about the Eversense CGM app.

Have a question? We're here to help.

Contact us >
Woman using her tablet to learn more about the Eversense CGM app.

Check out helpful articles, tips and more.

View resources >

*The opinions expressed belong solely to the individual. This information provides general information only. It is not intended to be used as medical advice, diagnosis or treatment and should not replace the advice of a Health Care Provider

 

Disclaimer

The Eversense® E3 Continuous Glucose Monitoring (CGM) System is indicated for continually measuring glucose levels for up to 180 days in persons with diabetes age 18 and older. The system is indicated for use to replace fingerstick blood glucose (BG) measurements for diabetes treatment decisions. Fingerstick BG measurements are still required for calibration primarily one time a day after day 21, and when symptoms do not match CGM information or when taking medications of the tetracycline class. The sensor insertion and removal procedures are performed by a health care provider. The Eversense E3 CGM System is a prescription device; patients should talk to their health care provider to learn more.
For safety information click here.

Eversense, Eversense E3 Continuous Glucose Monitoring and the Eversense logo are trademarks of Senseonics, Incorporated. Ascensia, and the Ascensia Diabetes Care logo are trademarks and/or registered trademarks of Ascensia Diabetes Care Holdings AG. All other trademarks are properties of their respective owners and are used solely for informative purposes. No relationship or endorsement should be inferred or implied.

Apple Watch® is a product of Apple, Inc., and may be separately purchased from an authorized Apple retailer. Apple Watch is not included with the Eversense CGM System. Android is a trademark of Google LLC.

Get Started